Latest Breaking News On - Prnewswire biofluidica - Page 1 : comparemela.com

BioFluidica Next-Generation Liquid Biopsy Platform Uncovers Undiagnosed HER2+ Patients

/PRNewswire/ Biofluidica today announced the results of a breast cancer study comparing invasive needle biopsies with their non-invasive, highly sensitive.

Brent kellerRolf mullerPrnewswire biofluidicaKay yeungJulie fergusonSanta clarajuneBiofluidica liquidscanBusiness development contactBiorepository tissue technology shared resourceBiofluidica incMoores cancer centerNext generation liquid biopsyNeogenomics laboratoriesCancer centerTissue technology shared resourcePrecision medicine world conference

BioFluidica Next-Generation Liquid Biopsy Platform Uncovers Undiagnosed HER2+ Patients

/PRNewswire/ Biofluidica today announced the results of a breast cancer study comparing invasive needle biopsies with their non-invasive, highly sensitive.

Brent kellerRolf mullerPrnewswire biofluidicaKay yeungJulie fergusonSanta clarajuneBiofluidica liquidscanBusiness development contactBiorepository tissue technology shared resourceBiofluidica incMoores cancer centerNext generation liquid biopsyNeogenomics laboratoriesCancer centerTissue technology shared resourcePrecision medicine world conference

BioFluidica Extends NIH Award through the Midwest Biomedical Accelerator Research Consortium for an At-Home Device Using Breakthrough Technology in the Fight Against COVID-19

/PRNewswire/ BioFluidica, a privately held biotechnology company, today announced they have been awarded a continuation grant from the Midwest Biomedical.

University of kansas medical centerUnited statesKansas cityUniversity of kansasBrent kellerPrnewswire biofluidicaBruce trombergJulie fergusonStevena soperBiofluidica liquidscanBusiness development contactMidwest biomedical accelerator research consortium mbarRadx advanced technology platformsDepartment of defenseKu news serviceBiofluidica inc

BioFluidica Announces Commercialization of its High Throughput LiquidScan™ Automated Liquid Biopsy System for Capturing Rare Biomarkers on a Single Scalable Platform

BioFluidica Announces Commercialization of its High Throughput LiquidScan™ Automated Liquid Biopsy System for Capturing Rare Biomarkers on a Single Scalable Platform
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesRolf mullerPrnewswire biofluidicaJulie fergusonBiofluidica incEarly technology access programAutomated liquid biopsyNon invasive prenatal screeningHamilton roboticsGood manufacturing practicesNorth americaCirculating tumor cellsஒன்றுபட்டது மாநிலங்களில்ரோல்ஃப் முல்லர்ஜூலி ஃபெர்குசன்அல்லாத ஆக்கிரமிப்பு ப்ரிநேடல் திரையிடல்

BioFluidica Announces Commercialization of its High Throughput LiquidScan™ Automated Liquid Biopsy System for Capturing Rare Biomarkers on a Single Scalable Platform